ANKRD40 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.119600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.772400E-01
Normal-vs-Stage2
8.313600E-01
Normal-vs-Stage3
1.240320E-02
Normal-vs-Stage4
4.318800E-01
Stage1-vs-Stage2
8.527400E-01
Stage1-vs-Stage3
9.558000E-03
Stage1-vs-Stage4
1.501960E-01
Stage2-vs-Stage3
4.394300E-02
Stage2-vs-Stage4
1.913000E-01
Stage3-vs-Stage4
2.598100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.979400E-01
Normal-vs-AfricanAmerican
8.790000E-01
Normal-vs-Asian
2.756000E-01
Caucasian-vs-AfricanAmerican
5.169800E-01
Caucasian-vs-Asian
8.946100E-02
AfricanAmerican-vs-Asian
1.730620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.620000E-01
Normal-vs-Female
8.677400E-01
Male-vs-Female
5.904000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.948000E-01
Normal-vs-Age(41-60Yrs)
6.142800E-01
Normal-vs-Age(61-80Yrs)
5.473400E-01
Normal-vs-Age(81-100Yrs)
7.000200E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.635200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.717400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.758800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.210100E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.43379999999416E-05
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.032400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.850610E-01
Normal-vs-Daily Drinker
2.179800E-01
Normal-vs-Weekly Drinker
8.878200E-01
Normal-vs-Occasional Drinker
7.353800E-01
Normal-vs-Social Drinker
5.744800E-01
Non Drinker-vs-Daily Drinker
9.601800E-01
Non Drinker-vs-Weekly Drinker
8.392300E-02
Non Drinker-vs-Occasional Drinker
1.112350E-02
Non Drinker-vs-Social Drinker
1.834340E-02
Daily Drinker-vs-Weekly Drinker
1.152220E-01
Daily Drinker-vs-Occasional Drinker
9.981200E-03
Daily Drinker-vs-Social Drinker
1.953740E-02
Weekly Drinker-vs-Occasional Drinker
4.221000E-01
Weekly Drinker-vs-Social Drinker
2.242800E-01
Occasional Drinker-vs-Social Drinker
5.165800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.451830E-01
Normal-vs-Grade 2
2.895600E-02
Normal-vs-Grade 3
2.336300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.032600E-01
Grade 1-vs-Grade 3
9.442200E-01
Grade 1-vs-Grade 4
1.451830E-01
Grade 2-vs-Grade 3
7.791800E-01
Grade 2-vs-Grade 4
2.895600E-02
Grade 3-vs-Grade 4
2.336300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.015200E-01
Normal-vs-NonDiabetic
8.249000E-01
Diabetic-vs-NonDiabetic
3.011400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.332600E-01
Normal-vs-NoPancreatitis
7.625400E-01
Pancreatitis-vs-NoPancreatitis
8.866800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.390400E-01
Normal-vs-N1
8.585400E-01
N0-vs-N1
5.601200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.742200E-01
Normal-vs-TP53-NonMutant
3.039000E-01
TP53-Mutant-vs-TP53-NonMutant
7.103400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
